Катамнез детей и подростков с поликистозом почек
Аннотация
Об авторе
Эльвира Фаатовна АндрееваРоссия
Список литературы
1. Андреева ЭФ, Папаян АВ, Савенкова НД. Поликистоз почек. В: Папаян АВ, Савенкова НД. ред. Клиническая нефрология детского возраста. Левша, СПб., 2008; 121-143 [Andreeva EF, Papayan AV, Savenkova ND. Polycystic kidney disease. V: Papayan AV, Savenkova ND, red. Clinical Nephrology in childchood. Levsha, St-Peterb., 2008; 121-143]
2. Андреева ЭФ, Савенкова НД. Кистозные болезни почек у детей (обзор литературы). Нефрология 2012; (16)3: 34-47 [Andreeva EF, Savenkova ND. Cystic kidney disease in children (review). Nephrologija 2012; (16)3: 34-47]
3. The classification of renal cystic diseases and other congenital malformations of the kidney and urinary tract. Arch Pathol Lab Med 2010; 134(4): 554-568
4. Арутюнян СС, Савенкова НД. Характеристика почечных и внепочечных проявлений аутосомно-доминантного поликистоза почек у детей. Нефрология 2013; (17)3: 60-67 ^rutyunyan SS, Savenkova ND. Characteristics of renal and extrarenal manifistations of autosomal dominant polycystic kidney disease in children. Nephrologija 2013; (17)3: 60-67]
5. Арутюнян СС, Савенкова НД, Ларионова ВИ. Аутосомно-доминантный поликистоз почек у взрослых и детей (обзор литературы). Нефрология 2010; (14)3: 58-68 [Arutyunyan SS, Savenkova ND, Larionova VI. Autosomal dominant polycystic kidney disease in children and adults. Nephrologija 2010; (14)3: 58-68]
6. Huang JL, Woolf AS, Long DA. Angiogenesis and autosomal dominant polycystic kidney disease. Pediatr Nephrol 2013; 28: 1749-1755
7. Grantham JJ. Rationale for early treatment of polycystic kidney disease. Pediatr Nephrol 2015; 30: 1053-1062
8. Gansevoort RT, Arici M, Benzing T et al. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrol Dial Transplant 2016; 31: 337-348
9. Spithoven EM, Kramer A, Meijer E et al. Renal replacement therapy for autosomal dominant polycystic kidney disease (AD-PKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry. Nephrol Dial Transplant 2014; 29: 15-25
10. Riella С, Czarnecki PG, Steinman TI. Therapeutic Advances in the Treatment of Polycystic Kidney Disease. Nephron Clin Pract 2014; 128: 297-302
11. Bergmann C. ARPKD and early manifestations of ADPKD: the original polycystic kidney disease and phenocopies. Pediatr Nephrol 2015; 30: 15-30
12. Guay-Woodford LM. Autosomal recessive polycystic kidney disease: the prototype of the hepato-renal fibrocystic diseases. J Pediatr Genet 2014; 3: 89-101
13. Büscher R, Büscher AK, Weber S. Clinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non-kidney-related phenotypes. Pediatr Nephrol 2014; 29:1915-1925
14. Sweeney Jr WE, Avner ED. Diagnosis and management of childhood polycystic kidney disease. Pediatr Nephrol 2011; 26: 675-692
15. Chapman AB, Devuyst O, Eckardt KU et al. Autosomaldominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2015; 88: 17-27
16. Sweeney Jr WE, Avner ED. Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy. Pediatric Research 2014; 75: 148-157
17. Liebau MC, Serra AL. Looking at the (w)hole: magnet resonance imaging in polycystic kidney disease. Pediatr Nephrol 2013; 28:1771-1783. doi: 10.1007/s00467-012-2370-y
18. Joshi SS, Paner GP, Chang SS. Polycystic Kidney Disease. In: The Kidney /edited by Hansel DE., Kane CJ., Paner GP., Chang SS. Springer. 2016; 19-35. doi: 10.1007/978-1-4939-3286-3
19. Avni FE, Hall M. Renal cystic deseases in children: new concepts. Pediatr Radiol 2010; 40: 939-946. doi: 10.1007/s00247-010-1599-5
20. Sweeney WE, Gunay-Aygun M, Patil A, Avner ED. Childhood Polycystic Kidney Disease. In: Pediatric Nephrology/ edited by Ellis Avner, William Harmon, Patrick Niaudet, Norishig Yoshikawa, Emma F, Goldstein S.L. - 7th ed. Springer. 2016; Part 6 (36): 11031153. 10.1007/978-3-662-43596-0_32
21. Dell KM. The spectrum of polycystic kidney disease in children. Adv Chronic Kidney Dis 2011; 18 (5): 339-347. doi: 10.1053/j.ackd.2011.05.001
Рецензия
Для цитирования:
Андреева Э.Ф. Катамнез детей и подростков с поликистозом почек. Нефрология. 2016;20(3):60-68.
For citation:
Andreeva E.F. The follow-up period of children and teenagers with polycystic kidney disease. Nephrology (Saint-Petersburg). 2016;20(3):60-68. (In Russ.)